HOME > ARCHIVE

ARCHIVE

BUSINESS NEWS IN BRIEF

April 17, 2006
GENERIC NEWS IN BRIEF

April 17, 2006
Council to Collect Evidence on Pediatric Use of 5 Drugs

April 17, 2006
Ordinance Issued on Designation of Vaccines as Orphan Drugs

April 17, 2006
REGULATORY NEWS IN BRIEF

April 17, 2006
BOOK

April 17, 2006
EPS Establishes Subsidiary to Support Clin. Trials in Asia

April 17, 2006
BUSINESS NEWS IN BRIEF

April 10, 2006
JMA

April 10, 2006
FY2006 Budget Proposal Approved

April 10, 2006
39 of World's 99 Top-Selling Drugs Unapproved in Japan: Mr Wolf of PhRMA

April 10, 2006
Korosho to Gear Up Steps to Eliminate Provisional Delivery

April 10, 2006
Economist Conferences: 5th Roundtable on Healthcare Reform in Japan

April 10, 2006
REGULATORY NEWS IN BRIEF

April 10, 2006
Daiichi Sankyo Selects 5 Top-Priority Projects

April 10, 2006
Ono, Medarex in Collaboration to Develop Antibody Therapeutics

April 10, 2006
R&D NEWS IN BRIEF

April 10, 2006
NEW BOOK

April 10, 2006
SEMINAR

April 10, 2006
Growing Need for Generics with High Added Value: Prof. Ueno

April 10, 2006

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s FY2026 R&D Tax Credit Reform Wins Broad Industry Backing

By Sakura Kono

Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…